All News

2057 articles, sorted by publication time.

Cancer Biology · us

Where Are Cancer Cells’ Weaknesses Hidden? Pericentromeric Replication Barriers Increase Sensitivity to PARP Inhibitors

Reducing ESCO2 makes cancer cells more vulnerable to PARP inhibitors even when they retain the homologous recombination repair responses tested. A new study points to replication difficulties at specific chromosomal locations, offering clues for predicting drug responses, but its use in selecting treatments for patients has not been established.